Aberrant Expression of Ether à Go-go Potassium Channel in Colorectal Cancer Patients and Cell Lines

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2007 Apr 25

PMID 17451210

Citations 29

Authors

Xiang-Wu Ding

Juan-Juan Yan

Ping An

Peng Lu

He-Sheng Luo

Affiliations

Soon will be listed here.

Abstract

Aim: To study the expression of ether à go-go (Eag1) potassium channel in colorectal cancer and the relation-ship between their expression and clinico-pathological features.

Methods: The expression levels of Eag1 protein were determined in 76 cancer tissues with paired non-cancerous matched tissues as well as 9 colorectal adenoma tissues by immunohistochemistry. Eag1 mRNA expression was detected in 13 colorectal cancer tissues with paired non-cancerous matched tissues and 4 colorectal adenoma tissues as well as two colorectal cancer cell lines (LoVo and HT-29) by reverse transcription PCR.

Results: The frequency of positive expression of Eag1 protein was 76.3% (58/76) and Eag1 mRNA was 76.9% (10/13) in colorectal cancer tissue. Expression level of Eag1 protein was dependent on the tumor size, lymphatic node metastasis, other organ metastases and Dukes' stage (P < 0.05), while not dependent on age, sex, site and degree of differentiation. Eag1 protein and mRNA were negative in normal colorectal tissue, and absolutely negative in colorectal adenomas except that one case was positively stained for Eag1 protein.

Conclusion: Eag1 protein and mRNA are aberrantly expressed in colorectal cancer and occasionally expressed in colorectal adenoma. The high frequency of expression of Eag1 in tumors and the restriction of normal expression to the brain suggest the potential of this protein for diagnostic, prognostic and therapeutic purposes.

Citing Articles

Intracellular hemin is a potent inhibitor of the voltage-gated potassium channel Kv10.1.

Sahoo N, Yang K, Coburger I, Bernert A, Swain S, Gessner G Sci Rep. 2022; 12(1):14645.

PMID: 36030326 PMC: 9420133. DOI: 10.1038/s41598-022-18975-2.

Alterations of Ion Homeostasis in Cancer Metastasis: Implications for Treatment.

Fnu G, Weber G Front Oncol. 2022; 11:765329.

PMID: 34988012 PMC: 8721045. DOI: 10.3389/fonc.2021.765329.

Antibodies Targeting K Potassium Channels: A Promising Treatment for Cancer.

Hernandez-Resendiz I, Hartung F, Pardo L Bioelectricity. 2021; 1(3):180-187.

PMID: 34471820 PMC: 8370288. DOI: 10.1089/bioe.2019.0022.

Potassium channels in intestinal epithelial cells and their pharmacological modulation: a systematic review.

Cosme D, Estevinho M, Rieder F, Magro F Am J Physiol Cell Physiol. 2020; 320(4):C520-C546.

PMID: 33326312 PMC: 8424539. DOI: 10.1152/ajpcell.00393.2020.

Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis.

Duranti C, Arcangeli A Antibodies (Basel). 2019; 8(2).

PMID: 31544839 PMC: 6640718. DOI: 10.3390/antib8020033.

References

Bauer C, Schwarz J . Physiology of EAG K+ channels. J Membr Biol. 2001; 182(1):1-15. DOI: 10.1007/s00232-001-0031-3. View

Ouadid-Ahidouch H, Le Bourhis X, Roudbaraki M, Toillon R, Delcourt P, Prevarskaya N . Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channel. Recept Channels. 2001; 7(5):345-56. View

Gavrilova-Ruch O, Schonherr K, Gessner G, Schonherr R, Klapperstuck T, Wohlrab W . Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells. J Membr Biol. 2002; 188(2):137-49. DOI: 10.1007/s00232-001-0181-3. View

Farias L, Ocana D, Diaz L, Larrea F, Avila-Chavez E, Cadena A . Ether a go-go potassium channels as human cervical cancer markers. Cancer Res. 2004; 64(19):6996-7001. DOI: 10.1158/0008-5472.CAN-04-1204. View

Kaplan W, Trout 3rd W . The behavior of four neurological mutants of Drosophila. Genetics. 1969; 61(2):399-409. PMC: 1212165. DOI: 10.1093/genetics/61.2.399. View

Hemmerlein B, Weseloh R, Mello de Queiroz F, Knotgen H, Sanchez A, Rubio M . Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer. 2006; 5:41. PMC: 1621079. DOI: 10.1186/1476-4598-5-41. View

Meyer R, Heinemann S . Characterization of an eag-like potassium channel in human neuroblastoma cells. J Physiol. 1998; 508 ( Pt 1):49-56. PMC: 2230852. DOI: 10.1111/j.1469-7793.1998.049br.x. View

Occhiodoro T, Bernheim L, Liu J, Bijlenga P, Sinnreich M, Bader C . Cloning of a human ether-a-go-go potassium channel expressed in myoblasts at the onset of fusion. FEBS Lett. 1998; 434(1-2):177-82. DOI: 10.1016/s0014-5793(98)00973-9. View

Pardo L, del Camino D, Sanchez A, Alves F, Bruggemann A, Beckh S . Oncogenic potential of EAG K(+) channels. EMBO J. 1999; 18(20):5540-7. PMC: 1171622. DOI: 10.1093/emboj/18.20.5540. View

10.

Weber C, Mello de Queiroz F, Downie B, Suckow A, Stuhmer W, Pardo L . Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference. J Biol Chem. 2006; 281(19):13030-13037. DOI: 10.1074/jbc.M600883200. View

11.

Mello de Queiroz F, Suarez-Kurtz G, Stuhmer W, Pardo L . Ether à go-go potassium channel expression in soft tissue sarcoma patients. Mol Cancer. 2006; 5:42. PMC: 1618397. DOI: 10.1186/1476-4598-5-42. View

12.

Warmke J, Ganetzky B . A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci U S A. 1994; 91(8):3438-42. PMC: 43592. DOI: 10.1073/pnas.91.8.3438. View